These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 10929704)

  • 21. [Weight loss via drug therapy].
    Wirth A
    Internist (Berl); 2003 Mar; 44(3):359-62, 363-6. PubMed ID: 12731423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pharmacological treatment of obesity: past, present and future].
    Simonyi G; Pados G; Medvegy M; Bedros JR
    Orv Hetil; 2012 Mar; 153(10):363-73. PubMed ID: 22370224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward optimal health: the experts discuss weight control drugs. Interview by Jodi Godfrey Meisler.
    Blackburn GL; Fernstrom MH
    J Womens Health Gend Based Med; 2001 Mar; 10(2):101-7. PubMed ID: 11268295
    [No Abstract]   [Full Text] [Related]  

  • 24. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical strategies for weight loss in the overweight and obese patient.
    Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current pharmacological approaches to the treatment of obesity.
    Hauner H
    Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S102-6. PubMed ID: 11466601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pharmacotherapy of obesity].
    Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
    Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New therapeutic options in obesity].
    Heufelder AE
    MMW Fortschr Med; 2003 Oct; 145(42):35-9. PubMed ID: 14655442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and management of the obese adult female: a clinical update for providers.
    Salazar SS
    J Midwifery Womens Health; 2006; 51(3):202-7. PubMed ID: 16647672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What role for weight-loss medication? Weighing the pros and cons for obese patients.
    Wyatt HR; Hill JO
    Postgrad Med; 2004 Jan; 115(1):38-40, 43-5, 58. PubMed ID: 14755876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for obesity.
    Halford JC
    Appetite; 2006 Jan; 46(1):6-10. PubMed ID: 16229924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [No progress without the physician in therapy of obesity].
    Schmidt H; Plauth M
    MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095
    [No Abstract]   [Full Text] [Related]  

  • 34. [Struggle about the best reducing diet, Fat gone by means of more fat?].
    Bischoff A
    MMW Fortschr Med; 2004 Jan; 146(1-2):4-6. PubMed ID: 18441569
    [No Abstract]   [Full Text] [Related]  

  • 35. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ; Ernest P
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orlistat for obesity.
    Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767
    [No Abstract]   [Full Text] [Related]  

  • 38. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
    Coutinho W
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonpharmacologic and pharmacologic management of weight gain.
    Greenberg I; Chan S; Blackburn GL
    J Clin Psychiatry; 1999; 60 Suppl 21():31-6. PubMed ID: 10548140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity.
    Finer N
    Clin Med (Lond); 2003; 3(1):23-7. PubMed ID: 12617409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.